IOL CHEMICALS & PHARM. | MEDPLUS HEALTH SERVICES | IOL CHEMICALS & PHARM./ MEDPLUS HEALTH SERVICES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | 138.1 | 10.0% | View Chart |
P/BV | x | 1.6 | 5.5 | 28.3% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. MEDPLUS HEALTH SERVICES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
MEDPLUS HEALTH SERVICES Mar-23 |
IOL CHEMICALS & PHARM./ MEDPLUS HEALTH SERVICES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 1,047 | 51.3% | |
Low | Rs | 272 | 570 | 47.8% | |
Sales per share (Unadj.) | Rs | 377.6 | 382.0 | 98.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | 4.2 | 564.3% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 19.4 | 162.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 122.4 | 209.8% | |
Shares outstanding (eoy) | m | 58.71 | 119.31 | 49.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.1 | 50.6% | |
Avg P/E ratio | x | 17.1 | 192.5 | 8.9% | |
P/CF ratio (eoy) | x | 12.8 | 41.6 | 30.8% | |
Price / Book Value ratio | x | 1.6 | 6.6 | 23.8% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 96,459 | 24.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 5,451 | 30.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 45,576 | 48.6% | |
Other income | Rs m | 256 | 461 | 55.6% | |
Total revenues | Rs m | 22,427 | 46,037 | 48.7% | |
Gross profit | Rs m | 2,257 | 2,814 | 80.2% | |
Depreciation | Rs m | 462 | 1,816 | 25.4% | |
Interest | Rs m | 165 | 987 | 16.7% | |
Profit before tax | Rs m | 1,887 | 472 | 400.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -29 | -1,682.9% | |
Profit after tax | Rs m | 1,391 | 501 | 277.7% | |
Gross profit margin | % | 10.2 | 6.2 | 164.9% | |
Effective tax rate | % | 26.2 | -6.2 | -420.7% | |
Net profit margin | % | 6.3 | 1.1 | 570.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 14,807 | 65.3% | |
Current liabilities | Rs m | 5,025 | 4,766 | 105.4% | |
Net working cap to sales | % | 20.9 | 22.0 | 95.0% | |
Current ratio | x | 1.9 | 3.1 | 61.9% | |
Inventory Days | Days | 43 | 10 | 448.9% | |
Debtors Days | Days | 8 | 1 | 1,200.6% | |
Net fixed assets | Rs m | 11,017 | 12,838 | 85.8% | |
Share capital | Rs m | 587 | 239 | 246.1% | |
"Free" reserves | Rs m | 14,490 | 14,369 | 100.8% | |
Net worth | Rs m | 15,077 | 14,607 | 103.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 27,645 | 74.8% | |
Interest coverage | x | 12.5 | 1.5 | 842.8% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.6 | 65.0% | |
Return on assets | % | 7.5 | 5.4 | 139.7% | |
Return on equity | % | 9.2 | 3.4 | 269.0% | |
Return on capital | % | 13.6 | 10.0 | 136.2% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 904 | 135.2% | |
From Investments | Rs m | -1,200 | 4,294 | -27.9% | |
From Financial Activity | Rs m | -41 | -1,702 | 2.4% | |
Net Cashflow | Rs m | -18 | 3,496 | -0.5% |
Indian Promoters | % | 48.2 | 40.4 | 119.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 37.4 | 4.5% | |
FIIs | % | 1.4 | 14.9 | 9.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 59.6 | 86.9% | |
Shareholders | 130,003 | 74,976 | 173.4% | ||
Pledged promoter(s) holding | % | 0.0 | 54.2 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | MEDPLUS HEALTH SERVICES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.84% | 0.41% | -0.27% |
1-Month | 6.42% | -2.63% | -0.36% |
1-Year | -1.58% | -6.65% | 53.36% |
3-Year CAGR | -12.79% | -15.49% | 14.81% |
5-Year CAGR | 17.57% | -9.61% | 19.73% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the MEDPLUS HEALTH SERVICES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of MEDPLUS HEALTH SERVICES the stake stands at 40.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of MEDPLUS HEALTH SERVICES.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
MEDPLUS HEALTH SERVICES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of MEDPLUS HEALTH SERVICES.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.